Balanced news tone
News Sentiment
ICU sentiment intelligence
SeaStar Medical Holding Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-19.2% over one week, +28.2% over four weeks, trend active, and below fair value.
KeyBanc raises ICU Medical stock price target on pump growth
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
KeyBanc raises ICU Medical stock price target on pump growth
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 21 Jul 2026 12:59
- Source
- Investing.com
ICU Medical (ICUI) Expands Austin IV Capacity, Is The Stock Already Pricey?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jul 2026 09:26
- Source
- simplywall.st
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 18:49
- Source
- Market source
ICU Medical stock hits 52-week high at 162.53 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 13:51
- Source
- Investing.com
Will US$500 Million Non-DEHP IV Expansion in Texas Change ICU Medical's (ICUI) Narrative
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2026 20:47
- Source
- simplywall.st
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 12:34
- Source
- GlobeNewswire
SeaStar Medical sponsors pediatric kidney injury summit
SeaStar Medical (NASDAQ: ICU) is sponsoring the KidneyBee Summit 2026 and an educational webinar to address pediatric acute kidney injury. The company's QUELIMMUNE therapy, approved for critically ill children with AKI and sepsis, has shown high survival rates in clinical trials.
- Tone
- Positive 74/100
- Event
- Macro sensitivity
- Published
- 14 Jul 2026 13:10
- Source
- Investing.com
SeaStar Medical: More Than 50% of Children With Severe Kidney Injury Die
SeaStar Medical (Nasdaq: ICU) announced its sponsorship of key educational initiatives to improve critical care for pediatric patients suffering from acute kidney injury (AKI), a condition that tragically leads to the death of over 50% of affected children in ICUs. The company is
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 12:11
- Source
- Stock Titan
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
How ICU Medical plans to shore up U.S. IV solution supply
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 09 Jul 2026 07:00
- Source
- Stock Titan
4,000-share RSU grant to SeaStar Medical (ICU) director disclosed
SeaStar Medical Holding Corp. (ICU) director Bernadette N. Vincent was granted 4,000 restricted stock units (RSUs) on July 1, 2026, which will vest in full on July 1, 2027. The grant was awarded at $0.00 per share, indicating a compensation grant rather than a purchase. This tran
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 02:10
- Source
- Stock Titan
SeaStar Medical (NASDAQ: ICU) director receives 4,000 restricted stock units
SeaStar Medical (NASDAQ: ICU) director Jennifer A. Baird was granted 4,000 restricted stock units (RSUs) which will fully vest on July 1, 2027. Following this award, her direct holdings in the company's common stock now total 10,620 shares. This transaction was reported in a Form
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:11
- Source
- Stock Titan
SeaStar Medical (ICU) director granted 4,000 restricted stock units
SeaStar Medical (ICU) director Kenneth Van Heel was granted 4,000 Restricted Stock Units (RSUs) on July 1, 2026. These RSUs will fully vest on July 1, 2027, provided he remains eligible. Following this grant, Van Heel directly holds 11,940 shares of the company's common stock.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:11
- Source
- Stock Titan
Form 4 SeaStar Medical Holding Corp For: 2 July By Investing.com
This article from Investing.com reports on a Form 4 filing for SeaStar Medical Holding Corp for the date of July 2nd. The content appears to be a brief announcement with financial market data and popular news headlines, but does not contain detailed information about the Form 4 i
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:11
- Source
- Investing.com Canada
SeaStar Medical (ICU) CEO receives 10,288 restricted stock units in equity grant
SeaStar Medical Holding Corp's CEO, Eric Schlorff, has been granted 10,288 restricted stock units (RSUs) as an equity award, not an open-market purchase. These RSUs, valued at $0.00 per share, will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:11
- Source
- Stock Titan
SeaStar Medical (ICU) director awarded 4,000 RSUs, holdings now 16,200 shares
SeaStar Medical director John Neuman was awarded 4,000 Restricted Stock Units (RSUs) as compensation, not through an open-market purchase. These RSUs will fully vest on July 1, 2027. Following this grant, Neuman's total holdings in SeaStar Medical common stock now stand at 16,200
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 21:11
- Source
- Stock Titan
SeaStar Medical (ICU) adopts 2026 retention bonus program for top executives
SeaStar Medical Holding Corporation has approved a 2026 Retention Bonus Program for executives Eric Schlorff ($200,000) and Kevin Chung ($140,000). The bonuses will be paid in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, subject to continued empl
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 19:39
- Source
- Stock Titan
SeaStar Medical (ICU) grants CMO 7,202 restricted stock units
SeaStar Medical Holding Corp. has granted its Chief Medical Officer, Kevin Chung, 7,202 restricted stock units (RSUs) as part of his compensation, at no cash cost to him. These RSUs will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027, bringi
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 30 Jun 2026 08:11
- Source
- Stock Titan
ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 07:00
- Source
- Market source
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
SeaStar Medical (Nasdaq: ICU) announced the acquisition of dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS) for its Selective Cytopheretic Device (SCD) therapy. These codes will enable standardized inpatient hospital billing and reporting for the
- Tone
- Positive 74/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 22:11
- Source
- Market source
SeaStar Medical (NASDAQ: ICU) amends Mr. Green separation deal
SeaStar Medical Holding Corporation (NASDAQ: ICU) filed an amended 8-K report clarifying a new separation and release agreement with Mr. Green, entered into on June 10, 2026. This amendment updates terms related to his disputed not-for-cause termination, with SeaStar Medical agre
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 20:42
- Source
- Stock Titan
Hospitals get new billing codes for SeaStar Medical’s kidney therapy
SeaStar Medical (Nasdaq: ICU) announced that its Selective Cytopheretic Device (SCD) therapy for acute kidney injury requiring renal replacement therapy has received dedicated ICD-10-PCS codes from the Centers for Medicare & Medicaid Services (CMS). These new codes, effective Oct
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 23 Jun 2026 12:42
- Source
- Stock Titan
SeaStar Medical Holding Corp (ICUCW) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of SeaStar Medical Holding Corp (ICUCW), detailing its current stock price, market capitalization, and various technical indicators. The analysis shows a prevailing "Sell" signal based on both technical indicators and moving averages, wi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 12:09
- Source
- TradingKey
SeaStar Medical to Present at Upcoming Investor Summit Conference
SeaStar Medical Holding Corporation announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24th at 10:30 am Eastern Time. The company, focused on treatments for critically ill patients, recently received FDA approval for QUELIMMUNE® (SCD-P
- Tone
- Positive 71/100
- Event
- Regulatory and legal
- Published
- 22 Jun 2026 12:39
- Source
- Market source
SeaStar Medical CEO to present at virtual investor summit June 24
SeaStar Medical (Nasdaq: ICU) announced that CEO Eric Schlorff will present at the Virtual Investor Summit Conference on June 24, 2026, at 10:30 a.m. Eastern Time. The company, a commercial-stage healthcare firm, focuses on treatments for critically ill patients with organ failur
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 12:39
- Source
- Stock Titan
SeaStar Medical Holding Corp (ICUCW) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for SeaStar Medical Holding Corp (ICUCW), focusing on its PE, PB, P/S, and P/CF ratios. The analysis indicates that relevant data for these metrics have not yet been disclosed by the company. TradingKey provides this financial informatio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 11:10
- Source
- TradingKey
SeaStar Medical Holding Corp (ICUCW) Institutional Confidence
This article provides details on the institutional confidence in SeaStar Medical Holding Corp (ICUCW), including its stock price, market cap, and a breakdown of institutional shareholdings. The data shows key institutional investors and their changes in shares held, with some fir
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 11:10
- Source
- TradingKey
SeaStar Medical Holding Corp
This article provides an overview of SeaStar Medical Holding Corp (ICU), including its current stock price and key financial metrics like market capitalization. It indicates that detailed revenue breakdown by business segment and region has not yet been disclosed by the company.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jun 2026 08:11
- Source
- TradingKey
SeaStar Medical Holding Corp (ICUCW) Financial Health: Profitability & Balance Sheet Analysis
This article from TradingKey provides an overview of SeaStar Medical Holding Corp's (ICUCW) financial health, specifically focusing on profitability and balance sheet analysis. It notes that relevant financial data for key metrics such as cash and equivalents, total assets, liabi
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 19 Jun 2026 08:10
- Source
- TradingKey
SeaStar Medical shareholders approve equity plan expansion and board election
SeaStar Medical shareholders have approved all proposals at their annual meeting, including the election of John Neuman as a Class I director and an amendment to expand the company's 2022 Omnibus Incentive Plan. They also ratified the appointment of WithumSmith+Brown, PC as their
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 18 Jun 2026 21:39
- Source
- Investing.com